Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TYMP | P19971 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALB | P02768 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | TK1 | P04183 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15422063 | 0.78 | — | — | |
| SCHEMBL16248 | 0.76 | MAPK1 (0.47) | MAPK1HPGDCRBNALDH1A1TYMP | |
| SCHEMBL17041835 | 0.76 | TDP1 (0.53) | TDP1MAPK1HPGDCRBNPOLB | |
| SCHEMBL400005 | 0.74 | TDP1 (1.00) | TDP1CRBNALDH1A1POLB | |
| SCHEMBL9192075 | 0.74 | TDP1 (0.57) | TDP1HPGDCRBNALDH1A1TYMP | |
| SCHEMBL5176789 | 0.74 | MAPK1 (0.46) | TDP1MAPK1HPGDALDH1A1TYMP | |
| SCHEMBL710870 | 0.74 | MAPK1 (0.46) | MAPK1HPGDALDH1A1TYMPLMNA | |
| SCHEMBL9190653 | 0.74 | TDP1 (0.57) | TDP1CRBNTYMPBLMTK1 | |
| SCHEMBL9192590 | 0.74 | TDP1 (0.57) | TDP1HPGDCRBNALDH1A1LMNA | |
| SCHEMBL7141531 | 0.74 | MAPK1 (0.46) | MAPK1HPGDALDH1A1TYMPLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059537-A1 | THERAPEUTIC OLIGONUCLEOTIDES HAVING AN INTER-NUCLEOSIDE AMIDE LINKAGE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2025-02-20 | — | — | US | disclosed |
| EP-4448541-A1 | THERAPEUTIC OLIGONUCLEOTIDES HAVING AN INTER-NUCLEOSIDE AMIDE LINKAGE | Oxford University Innovation Limited (GB) | 2024-10-23 | — | — | EP | disclosed |
| WO-2023178230-A1 | PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER CONJUGATES | SAREPTA THERAPEUTICS, INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| WO-2023111597-A1 | THERAPEUTIC OLIGONUCLEOTIDES HAVING AN INTER-NUCLEOSIDE AMIDE LINKAGE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-06-22 | — | — | WO | disclosed |
| EP-4115908-A1 | EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY | Sarepta Therapeutics, Inc. (US) | 2023-01-11 | — | — | EP | disclosed |
| WO-2021108640-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | DTX PHARMA, INC. (US) | 2021-06-03 | — | — | WO | disclosed |
| WO-2021108662-A1 | COMPOUND COMPRISING A NUCLEIC ACID AND A HALF-LIFE EXTENSION MOTIF | DTX PHARMA, INC. (US) | 2021-06-03 | — | — | WO | disclosed |
| WO-2021000380-A1 | MODIFIED NUCLEOSIDE, NUCLEOTIDE AND MODIFIED NUCLEIC ACID POLYMER, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 中国人民解放军军事科学院军事医学研究院 | 2021-01-07 | — | — | WO | disclosed |
| US-10871467-B2 | Cannabinoid profiling using nanopore transduction | Cannaptic Biosciences, LLC (US) | 2020-12-22 | — | — | US | disclosed |
| US-10822607-B2 | Site-specific induction of bimolecular quadruplex-duplex hybrids and methods of using the same | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-11-03 | — | — | US | disclosed |
| WO-2001016365-A1 | POLY(ETHER-THIOETHER), POLY(ETHER-SULFOXIDE) AND POLY(ETHER-SULFONE) NUCLEIC ACIDS | BIO-RAD LABORATORIES, INC. (US) | 2001-03-08 | — | — | WO | disclosed |
| CN-1236395-A | Real-time homogeneous nucleotide assay | EDWARD E WINGER (US) | 1999-11-24 | — | — | CN | disclosed |
| US-5773571-A | BOND TO RNA AND DNA STRANDS | NIELSEN PETER E (DK) | 1998-06-30 | — | — | US | disclosed |
| EP-0688364-A4 | GENETICALLY ENGINEERED ENZYMES AND THEIR CONJUGATES FOR DIAGNOSTIC ASSAYS | ABBOTT LAB (US) | 1997-10-15 | — | — | EP | disclosed |
| US-5539082-A | Peptide nucleic acids | NIELSEN PETER E (DK) | 1996-07-23 | — | — | US | disclosed |
| EP-0699208-A1 | NOVEL PEPTIDE NUCLEIC ACIDS | NIELSEN, Peter Eigil (DK) | 1996-03-06 | — | — | EP | disclosed |
| EP-0688364-A1 | GENETICALLY ENGINEERED ENZYMES AND THEIR CONJUGATES FOR DIAGNOSTIC ASSAYS | ABBOTT LABORATORIES (US) | 1995-12-27 | — | — | EP | disclosed |
| WO-1994020636-A9 | GENETICALLY ENGINEERED ENZYMES AND THEIR CONJUGATES FOR DIAGNOSTIC ASSAYS | — | 1994-11-24 | — | — | WO | disclosed |
| WO-1994025477-A2 | NOVEL PEPTIDE NUCLEIC ACIDS | NIELSEN PETER E (DK) | 1994-11-10 | — | — | WO | disclosed |
| WO-1994020636-A1 | GENETICALLY ENGINEERED ENZYMES AND THEIR CONJUGATES FOR DIAGNOSTIC ASSAYS | ABBOTT LABORATORIES (US) | 1994-09-15 | — | — | WO | disclosed |